An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization

An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization

Background: Endometrial cancer (EC) is the most common gynecologic tumor and the world’s fourth most common cancer in women. Most patients respond to first-line treatments and have a low risk of recurrence, but refractory patients, and those with metastatic cancer at diagnosis, remain with no treatm...

Full description

Bibliographic Details
Main Authors: Federica Torricelli, Elisabetta Sauta, Veronica Manicardi, Vincenzo Dario Mandato, Andrea Palicelli, Alessia Ciarrocchi, Gloria Manzotti
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cells
Subjects:
drug repurposing
endometrial cancer
gene expression
metastasis
PI3K pathway
Online Access:https://www.mdpi.com/2073-4409/12/5/794

Similar Items

Similar Items